Indian Court Clears Mylan’s Atazanavir Exports
This article was originally published in PharmAsia News
Executive Summary
Generic drug maker Mylan has scored a significant victory in India over Bristol-Myers Squibb in its ongoing fight over HIV medicine atazanavir. A court in the country has allowed Mylan to export to Venezuela, a move that was vehemently opposed by BMS.